RE: Nuformix article with proactiveinvestors16 Dec 2019 17:05
“ On NPX001, its cancer care drug, Gooding admitted being “a bit let down” by Chinese partner Newsummit following a delay to payments owed to Nuformix.
“However, we are hoping to change that from a delay to a really positive story,” he added.”